TGFBI Antikörper
-
- Target Alle TGFBI Antikörper anzeigen
- TGFBI (Transforming Growth Factor, beta-Induced, 68kDa (TGFBI))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TGFBI Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Huhn, Human
- Produktmerkmale
-
Rabbit polyclonal antibody to TGFBI (transforming growth factor, beta-induced, 68 kDa)
TGFBI antibody [C1C3] - Aufreinigung
- Purified by antigen-affinity chromatography.
- Immunogen
- Recombinant protein encompassing a sequence within the center region of human TGFBI. The exact sequence is proprietary.
- Isotyp
- IgG
- Top Product
- Discover our top product TGFBI Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Kommentare
-
Positive Control: HeLa
Validation: Orthogonal
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion." in: Scientific reports, Vol. 8, Issue 1, pp. 8822, (2019) (PubMed).
: "
-
Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion." in: Scientific reports, Vol. 8, Issue 1, pp. 8822, (2019) (PubMed).
-
- Target
- TGFBI (Transforming Growth Factor, beta-Induced, 68kDa (TGFBI))
- Andere Bezeichnung
- transforming growth factor beta induced (TGFBI Produkte)
- Synonyme
- TGFBI antikoerper, BIGH3 antikoerper, CDB1 antikoerper, CDG2 antikoerper, CDGG1 antikoerper, CSD antikoerper, CSD1 antikoerper, CSD2 antikoerper, CSD3 antikoerper, EBMD antikoerper, LCD1 antikoerper, 68kDa antikoerper, AI181842 antikoerper, AI747162 antikoerper, Beta-ig antikoerper, big-h3 antikoerper, Big-h3 antikoerper, MP70 antikoerper, MP78 antikoerper, hm:zeh0933 antikoerper, wu:fa13f05 antikoerper, zgc:110495 antikoerper, transforming growth factor beta induced antikoerper, transforming growth factor, beta induced antikoerper, transforming growth factor, beta-induced antikoerper, TGFBI antikoerper, Tgfbi antikoerper, tgfbi antikoerper
- Hintergrund
-
This gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy.
Cellular Localization: Secreted , extracellular space , extracellular matrix - Molekulargewicht
- 75 kDa
- Gen-ID
- 7045
- UniProt
- Q15582
-